Kidney Care Community News

Although the FDA accepted a new drug application for terlipressin to treat hepatorenal syndrome type 1, the agency has issued a complete response letter to Mallinckrodt plc stating that more data are required before the NDA can be approved.

Young adults who experienced episodes of kidney function decline – termed here as having greater end-stage renal disease risk exposure – had lower cognitive performance at middle age, according to a study published in Neurology.

Rick Barnett will retire after 6 years as CEO of Satellite Healthcare, the company announced Sept. 11.

Rockwell Medical Inc. has entered into a license agreement with Jeil Pharmaceutical Co. Ltd. for the rights to commercialize Triferic in South Korea.

Study findings showed Baxter’s medium cut-off dialyzer resulted in greater clearance of larger middle molecules than was seen with standard hemodialysis therapy. The device was recently granted de novo authorization by the FDA.

Study findings indicated that while most patients on dialysis reported that they wanted CPR performed if their “heart were to stop beating,” these preferences were not always associated with other aspects of end-of-life care.

Akebia Therapeutics Inc. said its investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor vadadustat reached primary and key secondary efficacy endpoints in phase 3 PRO2TECT cardiovascular outcomes studies.

Cannabis has been long misunderstood as a dangerous narcotic by federal regulators and has medicinal value for patients with chronic kidney disease, a speaker at the American Nephrology Nurses Association’s National Symposium said.

At the virtual Innovations in Dialysis: Expediting Advances Symposium, U.S. Rep. Suzan DelBene, D-Wash., assured the audience that Congress continues its efforts to improve care for patients with kidney disease.

A speaker at the virtual Innovations in Dialysis: Expediting Advances Symposium discussed how patient-preference information can be used by the FDA in making regulatory decisions on devices designed for patients with kidney failure.